IP Verse

Antibodies Against Human Cd39 And Use Thereof For Inhibiting T Regulatory Cells Activity - EP3153526

PATENT ANALYSIS

Patent Details

Grant Date
Sep 23, 2020
Company
INSERM - INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE
Oppositions

ABBVIE INC.

BOULT WADE TENNANT LLP

SURFACE ONCOLOGY, INC.

TRISHULA THERAPEUTICS, INC.

More patents of Inserm - Institut National De La Santé Et De La Recherche Médicale

EP3212200

EP3256573

EP3256574

Want to monitor this patent?

Feel free to send us a message here and we will get back to you